The Heart Failure Point-of-Care (POC) and Lab-on-Chip (LOC) Devices market is witnessing accelerated growth, driven by the rising global burden of cardiovascular diseases. According to the American Heart Association (AHA), approximately 6.2 million adults in the U.S. alone have heart failure, with the prevalence projected to increase by 46% by 2030. The economic burden is equally concerning, with annual healthcare costs for heart failure expected to surpass USD 70 billion by 2035. These statistics underscore the urgent need for innovative, cost-effective diagnostic and monitoring solutions.